Estimation of Apparent Tumor Vascular Permeability from Multiphoton Fluorescence Microscopic Images of P22 Rat Sarcomas In Vivo

REFERENCES

• Jain R K. Delivery of novel therapeutic agents into tumours: physiological barriers and strategies. JNCI 1989; 81: 570–576
   PubMed Web of Science ®Google Scholar
• Monsky W L, Mouta Carreira C, Tsuzuki Y, Gohongi T, Fukumura D, Jain R K. Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. Clin Cancer Res 2002; 8: 1008–1013
   PubMedGoogle Scholar
• Tozer G M, Kanthou C, Baguley B C. Disrupting tumour blood vessels. Nat Rev Cancer 2005; 5: 423–435
   PubMed Web of Science ®Google Scholar
• McDonald D M, Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res 2002; 62: 5381–5385
   PubMed Web of Science ®Google Scholar
• Baird L C, Canoll P, Bruce J. Effect of infiltrating tumor cells on the blood–brain barrier in a neonatal rat glioma model. Society for Neuro-Oncology Eighth Annual Meeting, Keystone, Colorado, 2003
   Google Scholar
• Nakano S, Matsukado K, Black K L. Increase brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res 1996; 56: 4027–4031
   PubMed Web of Science ®Google Scholar
• Inoue N, Venema R C, Sayegh H S, Ohara Y, Murphy T J, Harrison D G. Molecular regulation of the bovine endothelial nitric oxide synthase by transforming growth factor-beta 1. Arterioscler Thromb Vasc Biol 1995; 15: 1255–1261
   PubMed Web of Science ®Google Scholar
• Masters B R, So P TC. Antecedents of two-photon excitation laser scanning microscopy, microscopy research and technique. Microsc Res Tech 2004; 63: 3–11
   Google Scholar
• Yuan F, Leunig M, Berk D A, Jain R K. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc Res 1993; 45: 269–289
   PubMed Web of Science ®Google Scholar
• Dark G D, Hill S A, Prise V E, Tozer G M, Pettit G R, Chaplin D J. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. Cancer Res 1997; 57: 1829–1834
   PubMed Web of Science ®Google Scholar
• Grosios K, Holwell S E, McGown A T, Pettit G R, Bibby M C. In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug. Br J Cancer 1999; 81: 1318–1327
   PubMed Web of Science ®Google Scholar
• Tozer G M, Prise V E, Wilson J, Cemazar M, Shan S, Dewhirst M W, Barber P R, Vojnovic B, Chaplin D J. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Cancer Res 2001; 61: 6413–6422
   PubMed Web of Science ®Google Scholar
• Tozer G M, Prise V E, Wilson J, Locke R J, Vojnovic B, Stratford M RL, Dennis M F, Chaplin D J. Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues. Cancer Res 1999; 59: 1626–1634
   PubMed Web of Science ®Google Scholar
• Kanthou C, Tozer G M. The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells. Blood 2002; 99: 2060–2069
   PubMed Web of Science ®Google Scholar
• Gaede V, Günther O. Multidimensional access methods. ACM Computing Surveys 1998; 30: 170–231
   Web of Science ®Google Scholar
• de Castro E, Morandi C. Registration of translated and rotated images using finite Fourier transforms. IEEE Trans Pattern Anal Mach Intell 1987; 5: 700–703
   Google Scholar
• Hill D LG, Batchelor P G, Holden M, Hawkes D J. Medical image registration [invited topical review]. Phys Med Biol 2001; 46: R1–R45
   PubMed Web of Science ®Google Scholar
• Randen T, Husøy J H. Filtering for texture classification: a comparative study. IEEE Trans Pattern Anal Mach Intell 1999; 21: 291–310
   Web of Science ®Google Scholar
• Schroeter P, Bigun J. Hierarchical image segmentation by multi-dimensional clustering and orientation-adaptive boundary refinement. Pattern Recognition 1999; 28: 695–709, 1995
   Google Scholar
• Patlak C S, Blasberg R G, Fenstermacher J D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3: 1–7
   PubMed Web of Science ®Google Scholar
• Padhani A R, Choyke P L. New Techniques in Oncologic Imaging. CRC Press, Boca Raton, FL 2006
   Google Scholar
• Daldrup H, Shames D M, Wendland M, Okuhata Y, Link T M, Rosenau W, Lu Y, Brasch R C. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. Am J Roentgenol 1998; 171: 941–949
   PubMed Web of Science ®Google Scholar
• Daldrup H E, Shames D M, Husseini W, Wendland M F, Okuhata Y, Brasch R C. Quantification of the extraction fraction for gadopentetate across breast cancer capillaries. Magn Reson Med 1998; 40: 537–543
   Google Scholar
• Roberts H C, Roberts T P, Ley S, Dillon W P, Brasch R C. Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading. Acad Radiol 2002; 9: S151–S155, (Suppl 1)
   Google Scholar
• Romer W, Hanauske A R, Ziegler S, Thodtmann R, Weber W, Fuchs C, Enne W, Herz M, Nerl C, Garbrecht M, Schwaiger M. Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood 1998; 91: 4464–4471
   PubMed Web of Science ®Google Scholar
• Smith I C, Welch A E, Hutcheon A W, Miller I D, Payne S, Chilcott F, Waikar S, Whitaker T, Ah-See A K, Eremin O, Heys S D, Gilbert F J, Sharp P F. Positron emission tomography using [(18)F]-fluorodeoxy-77D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol 2000; 18: 1676–1688
   PubMed Web of Science ®Google Scholar
• Lodge M A, Lucas J D, Marsden P K, Cronin B F, O'Doherty M J, Smith M A. A PET study of 18FDG uptake in soft tissue masses. Eur J Nucl Med 1999; 26: 22–30
   PubMedGoogle Scholar
• Vesselle H, Schmidt R A, Pugsley J M, Li M, Kohlmyer S G, Vallires E, Wood D E. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 2000; 6: 3837–3844
   PubMed Web of Science ®Google Scholar
• Renkin E M. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 1959; 197: 1205–1210
   PubMed Web of Science ®Google Scholar
• Michel C C, Curry F E. Microvascular permeability. Physiol Rev 1999; 79: 703–761
   PubMed Web of Science ®Google Scholar
• Bickel U. How to measure drug transport across the blood–brain barrier. NeuroRx 2005; 2: 15–26
   PubMedGoogle Scholar
• Gerlowski L E, Jain R K. Microvascular permeability of normal and neoplastic tissues. Microvasc Res 1986; 31: 288–305
   PubMed Web of Science ®Google Scholar
• Prise V E, Honess D J, Stratford M RL, Wilson J, Tozer G M. The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses. Int J Oncol 2002; 21: 717–726
   PubMed Web of Science ®Google Scholar
• Briseid G, Briseid K. Inhibition by low molecular weight dextran of the blood pressure fall and the lowering of plasminogen proactivator induced by clinical dextran in the rat. Acta Pharmacol Toxicol (Copenh) 1983; 52: 143–149
   Google Scholar
• Prise V E, Honess D J, Stratford M RL, Wilson J, Tozer G M. The vascular response of tumor and normet tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses. Int J Oncol 2002; 2: 717–726
   Google Scholar